3 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
News 2026-10-19 12:34 UTC
NRx Pharmaceuticals completed three commercial process validation lots and reported two-year room-temperature stability for preservative-free ketamine ahead of a Nov. 10 GDUFA goal date for its ANDA.
News 2026-10-19 12:34 UTC
NRx Pharmaceuticals announced completion of manufacturing process validation and two-year stability of preservative-free ketamine.
News 2026-10-19 12:30 UTC
NRx Pharmaceuticals announced completion of manufacturing process validation and two-year stability for preservative-free ketamine.